MHC MACSimer 抗原特异性T细胞流式分析试剂盒

       抗原特异性免疫反应在癌症、感染性和自身免疫性疾病中发挥着重要作用。对抗原特异性T细胞进行直接的量化、可视化以及表征鉴定存在很大的难度。抗原特异性T细胞的分析最常见的方法是由生物素化的MHC单体在荧光标记的链霉亲和素上形成的四聚体技术。
       MHC MACSimers采用六个pMHC单体稳定的偶联在一个荧光素标记的多聚体主链上，具有优越的亮度、稳定性和特异性。
MHC MACSimer产品特点：

•  通过优化，实现最小的手动操作时间
• 高灵活性肽的加载，用于抗原表位的筛选
• 采用重组技术和直接偶联，具有很高的稳定性和特异性
• 由于独特的结构设计，实现优越的亮度和检测灵敏度
• 基于REAlease技术，可去除表面标记物
• 可以使用anti-PE微珠磁性富集

美天旎可订购产品信息：

• MHC MACSimer FleX产品

产品名称	货号	规格
MHC MACSimer A*2402 FleX Kit, human, PE	130-133-914	50 tests
MHC MACSimer A*2402 FleX Kit, human, PE	130-133-910	100 tests
MHC MACSimer A*0201 FleX Kit, human, PE	130-133-925	50 tests
MHC MACSimer A*0201 FleX Kit, human, PE	130-133-926	100 tests
MHC MACSimer H-2Kb FleX Kit, mouse, PE	130-133-909	50 tests
MHC MACSimer H-2Kb FleX Kit, mouse, PE	130-133-913	100 tests

• Peptide-loaded MACSimers产品

产品名称	货号	规格
MHC MACSimer A*0201 EBV LMP2a (CLGGLLTMV), human, PE	130-134-650	3× 150 µL
MHC MACSimer A*0201 MG50 (TLHCDCEIL), human, PE	130-134-644	3× 150 µL
MHC MACSimer H-2Kb Ovalbumin (SIINFEKL), mouse, PE	130-134-635	150 µL
MHC MACSimer A*2402 Survivin (AYACNTSTL), human, PE	130-134-630	150 µL
MHC MACSimer A*2402 HER-2/neu (TYLPTNASL), human, PE	130-134-631	150 µL
MHC MACSimer A*0201 EBV LMP2a (FLYALALLL), human, PE	130-134-649	3× 150 µL
MHC MACSimer A*0201 WT-1 (VLDFAPPGA), human, PE	130-134-646	3× 150 µL
MHC MACSimer A*2402 Control, human	130-134-669	3× 150 µL
MHC MACSimer H-2Kb Control, mouse	130-134-670	3× 150 µL
MHC MACSimer A*0201 CMV pp65 (NLVPMVATV), human, PE	130-134-651	3× 150 µL
MHC MACSimer A*2402 Survivin (AYACNTSTL), human, PE	130-134-659	3× 150 µL
MHC MACSimer H-2Kb VV B8R (TSYKFESV), mouse, PE	130-134-665	3× 150 µL
MHC MACSimer H-2Kb Ovalbumin (SIINFEKL), mouse, PE	130-134-664	3× 150 µL
MHC MACSimer A*2402 CMV IE1 (AYAQKIFKI), human, PE	130-134-629	150 µL
MHC MACSimer A*2402 HER-2/neu (TYLPTNASL), human, PE	130-134-660	3× 150 µL
MHC MACSimer A*2402 SARS CoV-2 S (QYIKWPWYI), human, PE	130-134-663	3× 150 µL
MHC MACSimer A*0201 IAV MP1 (GILGFVFTL), human, PE	130-134-652	3× 150 µL
MHC MACSimer A*0201 SARS CoV-2 ORF3a (LLYDANYFL), human, PE	130-134-654	3× 150 µL
MHC MACSimer A*0201 SARS CoV-2 S (YLQPRTFLL), human, PE	130-134-656	3× 150 µL
MHC MACSimer A*2402 gp100/pmel (VYFFLPDHL), human, PE	130-134-661	3× 150 µL
MHC MACSimer A*2402 gp100/pmel (VYFFLPDHL), human, PE	130-134-632	150 µL
MHC MACSimer A*0201 MG50 (TLHCDCEIL), human, PE	130-134-616	150 µL
MHC MACSimer A*0201 gp100/pmel (ITDQVPFSV), human, PE	130-134-619	150 µL
MHC MACSimer A*0201 EBV LMP2a (FLYALALLL), human, PE	130-134-621	150 µL
MHC MACSimer A*0201 MART-1 (ELAGIGILTV), human, PE	130-134-615	150 µL
MHC MACSimer A*0201 MART-1 (ELAGIGILTV), human, PE	130-134-643	3× 150 µL
MHC MACSimer A*2402 SARS CoV-2 S (QYIKWPWYI), human, PE	130-134-634	150 µL
MHC MACSimer A*2402 EBV LMP2a (PYLFWLAAI), human, PE	130-134-633	150 µL
MHC MACSimer A*0201 IAV MP1 (GILGFVFTL), human, PE	130-134-624	150 µL
MHC MACSimer A*0201 PRAME (SLLQHLIGL), human, PE	130-134-642	3× 150 µL
MHC MACSimer A*0201 SARS CoV-2 N (LLLDRLNQL), human, PE	130-134-655	3× 150 µL
MHC MACSimer A*0201 PRAME (SLLQHLIGL), human, PE	130-134-614	150 µL
MHC MACSimer A*0201 delNPM1 (CLAVEEVSL), human, PE	130-134-645	3× 150 µL
MHC MACSimer A*2402 CMV IE1 (AYAQKIFKI), human, PE	130-134-658	3× 150 µL
MHC MACSimer A*0201 EBV LMP2a (CLGGLLTMV), human, PE	130-134-622	150 µL
MHC MACSimer A*0201 HER-2/neu (RLLQETELV), human, PE	130-134-648	3× 150 µL
MHC MACSimer A*0201 delNPM1 (CLAVEEVSL), human, PE	130-134-617	150 µL
MHC MACSimer A*2402 EBV LMP2a (PYLFWLAAI), human, PE	130-134-662	3× 150 µL
MHC MACSimer H-2Kb SeV N (FAPGNYPAL), mouse, PE	130-134-666	3× 150 µL
MHC MACSimer A*2402 CMV pp65 (QYDPVAALF), human, PE	130-134-657	3× 150 µL
MHC MACSimer A*0201 Control, human	130-134-639	150 µL
MHC MACSimer A*0201 SARS CoV-2 ORF3a (LLYDANYFL), human, PE	130-134-626	150 µL
MHC MACSimer A*0201 SARS  CoV-2 N (LLLDRLNQL), human, PE	130-134-627	150 µL
MHC MACSimer A*2402 CMV pp65 (QYDPVAALF), human, PE	130-134-038	150 µL
MHC MACSimer A*0201 SARS CoV-2 S (YLQPRTFLL), human, PE	130-134-628	150 µL
MHC MACSimer A*0201 WT-1 (VLDFAPPGA), human, PE	130-134-618	150 µL
MHC MACSimer A*0201 HSP105 (KLMSSNSTDL), human, PE	130-134-625	150 µL
MHC MACSimer A*0201 CMV pp65 (NLVPMVATV), human, PE	130-134-623	150 µL
MHC MACSimer H-2Kb SIY Neo-Ag (SIYRYYGL), mouse, PE	130-134-667	3× 150 µL
MHC MACSimer A*0201 HER-2/neu (RLLQETELV), human, PE	130-134-620	150 µL
MHC MACSimer H-2Kb SeV N (FAPGNYPAL), mouse, PE	130-134-637	150 µL
MHC MACSimer H-2Kb Control, mouse	130-134-641	150 µL
MHC MACSimer A*0201 gp100/pmel (ITDQVPFSV), human, PE	130-134-647	3× 150 µL
MHC MACSimer A*2402 Control, human	130-134-640	150 µL
MHC MACSimer A*0201 Control, human	130-134-668	3× 150 µL
MHC MACSimer H-2Kb VV B8R (TSYKFESV), mouse, PE	130-134-636	150 µL
MHC MACSimer H-2Kb SIY Neo-Ag (SIYRYYGL), mouse, PE	130-134-638	150 µL
MHC MACSimer A*0201 HSP105 (KLMSSNSTDL), human, PE	130-134-653	3× 150 µL